# <p>Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs</p>

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/and-lt-p-and-gt-real-world-effectiveness-of-mepolizumab-in-patients-with-severe/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jean‐Pierre Llanos,Héctor Ortega,Michael Bogart,Elizabeth Packnett,Janna Manjelievskaia,Christopher F. Bell,Beth Hahn |
| Citations | 60 |
| DOI | 10.2147/jaa.s236609 |
| Fields | Medicine,Social Sciences |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.dovepress.com/getfile.php?fileID=55728 |
| OpenAlex ID | https://openalex.org/W3004234135 |
| PMID | 32099413 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Christopher F. Bell](https://scholariq.org/researchers/christopher-f-bell/)

## Paper primary topic

- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)

## Paper topics

- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Delphi Technique in Research](https://scholariq.org/topics/delphi-technique-in-research/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.